Cargando…
Early Urinary Metabolomics in Patent Ductus Arteriosus Anticipates the Fate: Preliminary Data
Introduction: In premature neonates, the persistence of hemodynamically significant ductus arteriosus (hsPDA) can be associated with short- and long-term consequences, impairing their outcome. The correct strategy of management for such condition is under debate, especially regarding contraindicatio...
Autores principales: | Bardanzellu, Flaminia, Piras, Cristina, Atzei, Alessandra, Neroni, Paola, Fanos, Vassilios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779766/ https://www.ncbi.nlm.nih.gov/pubmed/33409262 http://dx.doi.org/10.3389/fped.2020.613749 |
Ejemplares similares
-
Paracetamol in Patent Ductus Arteriosus Treatment: Efficacious and Safe?
por: Bardanzellu, Flaminia, et al.
Publicado: (2017) -
Echocardiographic Evaluation of Patent Ductus Arteriosus in Preterm Infants
por: Arlettaz, Romaine
Publicado: (2017) -
Isoprostanes as Biomarker for Patent Ductus Arteriosus in Preterm Infants
por: Coviello, Caterina, et al.
Publicado: (2020) -
Management of Patent Ductus Arteriosus in Premature Infants in 2020
por: Parkerson, Sarah, et al.
Publicado: (2021) -
Editorial: Management of Patent Ductus Arteriosus in Preterm Infants
por: Atasay, Begüm, et al.
Publicado: (2021)